1-4 of 4
Stephen Richards
Close
Sort by
Journal Articles

A Spontaneous Reduction of Clone Size in Paroxysmal Nocturnal Hemoglobinuria Patients Treated with Eculizumab for Greater Than 12 Months.

Richard Kelly, MBChB, Stephen Richards, PhD, Louise Arnold, BSc, MA, Gemma Valters, BSc, Matthew Cullen, MA, Anita Hill, MBChB, (Hons), PhD, Peter Hillmen, PhD
Journal: Blood
Blood (2009) 114 (22): 1992.
https://doi.org/10.1182/blood.V114.22.1992.1992
Published: 2009
Journal Articles

Modification of the Eculizumab Dose to Successfully Manage Intravascular Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Richard Kelly, MD, Louise Arnold, BSc, MA, Stephen Richards, PhD, Anita Hill, MD, Sandra vanBijnen, MD, Petra Muus, MD, PhD, Donna Dorr, RN, MSN, AOCN, Robert Brodsky, MD, Gus Khursigara, PhD, Russell P. Rother, PhD, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2008) 112 (11): 3441.
https://doi.org/10.1182/blood.V112.11.3441.3441
Published: 2008
Journal Articles

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

Charles Parker, Mitsuhiro Omine, Stephen Richards, Jun-ichi Nishimura, Monica Bessler, Russell Ware, Peter Hillmen, Lucio Luzzatto, Neal Young, Taroh Kinoshita, Wendell Rosse, Gerard Socié, for the International PNH Interest Group
Journal: Blood
Blood (2005) 106 (12): 3699–3709.
https://doi.org/10.1182/blood-2005-04-1717
Published: 2005
Includes: Supplemental data
Journal Articles

Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH)

Clinical Trials & Observations
Claire Hall, Stephen Richards, Peter Hillmen
Journal: Blood
Blood (2003) 102 (10): 3587–3591.
https://doi.org/10.1182/blood-2003-01-0009
Published: 2003